TRAC-AF Trial: First-in-man multicenter prospective clinical experience using a novel diamond tip temperature controlled irrigated ablation system: safety results and initial effectiveness performance
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F18%3A00102437" target="_blank" >RIV/00216224:14110/18:00102437 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1093/europace/euy015.168" target="_blank" >http://dx.doi.org/10.1093/europace/euy015.168</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/europace/euy015.168" target="_blank" >10.1093/europace/euy015.168</a>
Alternativní jazyky
Jazyk výsledku
čeština
Název v původním jazyce
TRAC-AF Trial: First-in-man multicenter prospective clinical experience using a novel diamond tip temperature controlled irrigated ablation system: safety results and initial effectiveness performance
Popis výsledku v původním jazyce
Background: A novel, low flow irrigated radiofrequency (RF) catheter with a diamond cooling tip to enable the physician to perform fast temperature-controlled ablations with rapid lesion assessment using high resolution electrograms (EGM) was evaluated in a first-in-man, prospective, multicenter, single-arm study. Methods: Patients with symptomatic, drug-refractory paroxysmal atrial fibrillation (PAF) underwent pulmonary vein isolation (PVI) with the new DiamondTip Ablation System. All patients were subsequently followed at 7 days, 1, 3, 6 and 12 months post procedure with a subset of patients undergoing remapping within the first 3 months post procedure.
Název v anglickém jazyce
TRAC-AF Trial: First-in-man multicenter prospective clinical experience using a novel diamond tip temperature controlled irrigated ablation system: safety results and initial effectiveness performance
Popis výsledku anglicky
Background: A novel, low flow irrigated radiofrequency (RF) catheter with a diamond cooling tip to enable the physician to perform fast temperature-controlled ablations with rapid lesion assessment using high resolution electrograms (EGM) was evaluated in a first-in-man, prospective, multicenter, single-arm study. Methods: Patients with symptomatic, drug-refractory paroxysmal atrial fibrillation (PAF) underwent pulmonary vein isolation (PVI) with the new DiamondTip Ablation System. All patients were subsequently followed at 7 days, 1, 3, 6 and 12 months post procedure with a subset of patients undergoing remapping within the first 3 months post procedure.
Klasifikace
Druh
O - Ostatní výsledky
CEP obor
—
OECD FORD obor
30101 - Human genetics
Návaznosti výsledku
Projekt
<a href="/cs/project/LQ1601" target="_blank" >LQ1601: CEITEC 2020</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2018
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů